Brief: Orbimed Advisors Llc Reports 18.9% Stake In Q32 Bio Inc As Of March 26 - SEC Filing
28/03/2024 21:08
March 28 (Reuters) - Q32 Bio Inc QTTB.O :
* ORBIMED ADVISORS LLC REPORTS 18.9% STAKE IN Q32 BIO INC AS
OF
MARCH 26 - SEC FILING
Source text for Eikon: [ID:https://bitly.ws/3gXRm]
Further company coverage: QTTB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview